UCLA State-of-the-Art Urology

Overview

Continuing Medical Education: Advances in Urology

Captured during the 46th annual conference, the UCLA State-of-the-Art Urology online CME course explores the most challenging management problems facing today’s practicing urologist. Distinguished faculty present the latest information, current therapies and expert techniques through 31 insightful lectures and nine panel discussions. Key topic areas include:

• Male and Female Voiding Dysfunction, Reconstruction, Urethral Stricture Disease
• Urolithiasis/Endourology
• Men’s Health – Penile Rehab, Priapism, Anorgasmia
• Prostate Cancer
• Bladder Cancer
• Testis Cancer
• Kidney Cancer

Topics / Speakers

Male and Female Voiding Dysfunction, Reconstruction, Urethral Stricture Disease

Evaluation and Treatment of Mixed Urinary Incontinence in Women 2021
Victor W. Nitti, MD

Tips on 3rd Line Therapies for Overactive Bladder – Videos Included
Kathleen C. Kobashi, MD, FACS

Evaluation and Management of Recurrent UTIs in Women
Kathleen C. Kobashi, MD, FACS

Value of Genetic Testing and Next Generation Sequencing in Diagnosis of UTI
A. Lenore Ackerman, MD, PhD

Panel Discussion: Voiding Dysfunction and UTIs in Women
Audience Questions – Case Presentations
Moderator: Dr. Ja-Hong Kim
Panel: Drs. Ackerman, Baxter, Kobashi, and Nitti

Management of Urethral Stricture Disease in 2021: Dilation, Incision, Reconstruction
Kurt A. McCammon, MD

Underactive Bladder and Bladder Outlet Obstruction in Men: Is Surgery Indicated?
Victor W. Nitti, MD

Are Male Slings a Good Option for Mild and Moderate Stress Incontinence in Men?
Kurt A. McCammon, MD

Panel Discussion: Male Voiding Dysfunction
Audience Questions – Case Presentations
Moderator: Dr. Victor W. Nitti
Panel: Drs. Baxter, Kim, Kobashi, and McCammon

Urolithiasis/Endourology

Metabolic Evaluation and Medical Management of Urolithiasis: A Simplified Approach (Stone Tree)
Ralph V. Clayman, MD

Antibiotic Use: Managing Pre and Post-Op Infections in Patients Undergoing Endoscopic Surgery
Matthew Dunn, MD

Death of the PCNL – Increasing Utilization of Ureteroscopy Now and in the Future
Ralph V. Clayman, MD

Ureteral Stents – A Love/Hate Relationship
Kymora Scotland, MD, PhD

Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Matthew Dunn
Panel: Drs. Clayman and Scotland

Men’s Health – Penile Rehab, Priapism, Anorgasmia

Rehab of the Penis Post-Prostatectomy – The Hopkins Experience
Arthur L. Burnett, MD, MBA

How and Why to Set Up a Men’s Health Clinic
Jesse N. Mills, MD

Medical and Surgical Approaches to Priapism
Arthur L. Burnett, MD, MBA

Anorgasmia: What, Why, and How to Treat
Sriram Eleswarapu, MD, PhD

Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Jacob Rajfer
Panel: Drs. Burnett, Eleswarapu, and Mills

Video Sessions

Single Port Robotic Surgery – Does This Advance Our Field?
Arnold I. Chin, MD, PhD

Robotic Radical Prostatectomy – Techniques for Optimizing Continence, Potency, and Negative Margins
Robert E. Reiter, MD, MBA

Prostate Cancer

10 Debunked Myths About Prostate Cancer
Scott Eggener, MD

Improving the Quality of Decision Making in Prostate Cancer Using Shared Decision Making
Christopher S. Saigal, MD, MPH

Personalizing Adjuvant vs. Early Salvage Radiotherapy
Daniel E. Spratt, MD

Focal Therapy for Prostate Cancer – State of the Art
Scott Eggener, MD

Active Surveillance in 2021: Update on Intensity of Follow Up and Inclusion of 3+4 Disease
Leonard S. Marks, MD

Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Eggener, Marks, Reiter, Saigal, and Spratt

Personalizing Hormone Therapy with Radiation Therapy Role for Biomarkers
Daniel E. Spratt, MD

Management of Oligometastatic Disease in the World of PSMA Imaging
Robert E. Reiter, MD, MBA

Update on Therapy for Advanced Prostate Cancer Integrating Genetic Testing
Matthew Rettig, MD

Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Eggener, Marks, Rettig, Reiter, and Spratt

Bladder Cancer

New Advances in Bladder Cancer in 2021
Karim Chamie, MD, MSHS

Updates for Non-Muscle Invasive Bladder Cancer During BCG Shortage
Sam S. Chang, MD, MBA

Advances in Upper Tract Urothelial Cancer
Sam S. Chang, MD, MBA

Panel Discussion and Case Presentations
Moderator: Dr. Mark S. Litwin Panel: Drs. Chamie, Chang, Chin, Drakaki, and Kishan

Testis Cancer

Everything a Urologist Needs to Know About Testis Cancer
Scott Eggener, MD

Panel Discussion – Audience Questions – Case Presentations
Moderator: Dr. Stanley K. Frencher, Jr.
Panel: Drs. Eggener, Drakaki, and Litwin

Kidney Cancer

Role for Elective Radical Nephrectomy for T1B/T2A Renal Tumors
Brian Shuch, MD

Management Considerations for Bilateral/Multifocal Renal Tumors
Brian Shuch, MD

Panel Discussion and Case Presentations
Moderator: Dr. Brian Shuch
Panel: Drs. Chamie, Liu, Padia, Pantuck, and Ye

Faculty

Accreditation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this enduring activity for a maximum of 16 AMA PRA Category 1 Credits™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: April 16, 2021
Date Credits Expire: April 15, 2024
Estimated Time to Complete: 16 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

Disclosure Statement

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the sponsor adequately manage all identified potential conflicts of interest prior to the program. We, at UCLA fully endorse the letter and spirit of these concepts.

Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.

Learning Objectives

At the completion of this program, participants should be better able to:

• Manage prostate cancer patients with active surveillance
• Utilize molecular markers for personalizing prostate cancer care
• Counsel patients on focal therapy for prostate cancer
• Utilize PSMA imaging for managing patients with oligometastatic prostate cancer
• Manage bladder cancer patients in the era of BCG shortages
• Manage patients with upper tract urothelial cancer
• Manage bilateral and multifocal renal tumors
• Treat patients with testis cancer
• Manage male and female voiding dysfunction
• Utilize male slings for post-prostatectomy incontinence
• Manage patients with kidney and ureteral stones
• Treat patients with priapism
• Utilize strategies for post-prostatectomy penile rehabilitation
• Understand and treat anorgasmia
• Understand the therapies for advanced prostate cancer and role for genetic testing
• Manage recurrent UTIs in women and utilize genetic testing for UTI diagnosis
• Manage urethral stricture disease
• Carry out a metabolic evaluation for urolithiasis
• Improve shared decision making in patients with prostate cancer

Intended Audience

This course explores the most challenging management problems facing the practicing urologist.

Quick Facts

Provider: David Geffen School of Medicine at UCLA

Course Chair:
William J. Aronson, MD

Course Co-Chairs:
Craig Canfield, MD
Karim Chamie, MD, MSHS

Credits: Earn a maximum of 16.00 AMA PRA Category 1 Credits™